Rein Therapeutics Inc

Market Cap

$92M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$0.94-$0.31 (-24.56%)

Jun 5, 2026

52W High $2.0052W Low $0.94

Company Details

Rein Therapeutics Inc., a biopharmaceutical company, focuses on developing medicines to address unmet medical needs in orphan pulmonary and fibrosis indications in the United States. The company's lead product candidate is LTI-03, a peptide...

CEO

—

IPO Date

Mar 12, 1986

Website

www.reintx.com

Key Metrics TTM

Revenue

- YoY

Net Income

-$50M

EPS (Diluted)

Free Cash Flow

-$17M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q1 2026

May 15, 2026

FY 2025

Mar 26, 2026

Q4 2025

Mar 26, 2026

Q3 2025

Nov 14, 2025

Q2 2025

Aug 14, 2025

Revenue & Profitability

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee